The effectiveness of tenoxicam in the treatment of dorsalgia
O.A. Shavlovskaya

Sechenov University, Moscow

Lower-back pain (LBP) remains an urgent problem due to its widespread. LBP is one of the most common among chronic pain syndromes, and the fifth most common cause of seeing a doctor.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered to be a gold standard in relieving back pain. Parenteral forms of administration NSAIDs (tenoxicam) to patients with dorsalgia reduces the duration of treatment, provides greater regression of pain and longer remissions. Tenoxicam belongs to the group of oxicams, non-selective inhibitors of cyclooxygenase. It is rapidly absorbed since the maximum plasma concentration is reached within 2 hours after intramuscular injection (the concentration is 90% or higher). Bioavailability of the drug by oral administration reaches 100%. Tenoxicam has a number of advantages in terms of speed and duration of the effect over other oxycams. It has been shown that tenoxicam therapy is quite equal to corticosteroid one. 

Key words: pain, lower-back pain, dorsalgia, nonsteroidal anti-inflammatory drugs, oxicam, tenoxicam, Texared.
For citation: Shavlovskaya O.A. The effectiveness of tenoxicam in the treatment of dorsalgia // RMJ. 2018. № 12(I). P. 49–52.